Gurnet Point Capital
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
55 Cambridge Pkwy Ste 401, Cambridge, Ma...Phone Number
(617) 588-4900Website
www.gurnetpointcapital.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
2
2
1
2
About Gurnet Point Capital
Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, who, together, have decades of expertise in an industry for which they share a passion, both as chief executives and as investors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new generation of companies. Based in Cambridge, Massachusetts, its remit is global, encompassing life sciences and medical technologies. The fund invests across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies.Explore more
Gurnet Point Capital Org Chart
EG
Project Manager
SR
Head of People Operating Partner
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gurnet Point Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Gurnet Point Capital launches new products
Check out if Gurnet Point Capital is spiking on competitors!
Gurnet Point Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Gurnet Point Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Gurnet Point Capital had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Gurnet Point Capital has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Gurnet Point Capital
Earning: See what the market has to say on Gurnet Point Capital recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Gurnet Point Capital as Masked Content
Find 2 more new buyers
Compare Similar Companies to Gurnet Point Capital
Compare insights from companies similar to Gurnet Point Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gurnet Point Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Gurnet Point Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Gurnet Point Capital.
Gurnet Point Capital Tech Stack
A closer look at the technologies used by Gurnet Point Capital
See more technologies
Most Recent Scoops
Left Company
Executive Move
New Hire
Executive Move
Executive Move
Board of Directors
New Hire
Executive Move
Project
Spending/Investment
Gurnet Point Capital News & Media
Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals
The purchase price is about $462 million. The post Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals appeared first on PE Hub.Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
Transaction Provides Paratek Shareholders with Immediate Value and LiquidityInnocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer | Business Wire
Innocoll Holdings Ltd. (“IHL”), a global biotech pharmaceutical company and portfolio business of Gurnet Point Capital (“GPC”), today announced the apCorium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, including transdermal modalities, today announced the appointment of Dr. Mark Sirgo as Chief Executive Officer and member of the Board of Directors. Dr. Sirgo is a pharmaceutical executive with over 35 years’ experience in the industry, including founding and servin
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gurnet Point Capital
Sign Up For FreeTo access detailed company insights
Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, who, together, have decades of expertise in an industry for which they share a passion, both as chief executives and as investors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in bu... Read More
